- Keywords > appropriate use
- Keywords > cost-effectiveness
- Keywords > Drug and Therapeutics Committee - DTC
- Keywords > drug use evaluation
- Keywords > evidence - effectiveness and efficiency
- Keywords > formulary - process
- Keywords > Good Prescribing Practice (GPP)
- Keywords > medicine use - investigating
- Keywords > new medicines - efficacy and safety
- Keywords > selection of medicines
(2003; 155 pages) [French] [Spanish] [Vietnamese]
Drug and Therapeutics Committees - A Practical Guide
World Health Organization
Department of Essential Drugs and Medicines Policy
In collaboration with
Management Sciences for Health
Center for Pharmaceutical Management
Rational Pharmaceutical Management Program
Arlington, Virginia, USA
Kathleen Holloway1 (Editor)
with contributions from: Edelisa Carandang,1 Hans Hogerzeil,1 Richard Laing,3 David Lee,2
The text was reviewed by: John Chalker,2 Mary Couper,1 Andrew Creese,1 Marthe Everard,1 Anna Paula di Felici,4 Chris Forshaw,5 David Henry,6 Yvan Hutin,7 Sabine Kopp,1 Souly Phanouvong,8 Clive Ondari,1 Lembit Rago,1 Marcus Reidenberg,9 Budiono Santoso,10 Anthony Savelli2 and Rosamund Williams.4
1 Department of Essential Drugs and Medicines Policy (EDM), World Health Organization, Geneva, Switzerland
2 Management Sciences for Health (MSH), Washington DC, USA*
3 Department of International Health, Boston University, Boston, Massachusetts, USA
4 Department of Communicable Disease Surveillance and Response, World Health Organization, Geneva, Switzerland
5 Uganda Health Sector Programme Support, Danida, Kampala, Uganda
6 Department of Clinical Pharmacology, University of Newcastle, New South Wales, Australia
7 Safe Injection Global Network, Department of Blood Safety and Clinical Technology, World Health Organization, Geneva, Switzerland
8 Global Assistance Initiatives, United States Pharmacopeia, Maryland, USA
9 Division of Clinical Pharmacology, Weill Medical College of Cornell University, New York, USA
10 Regional Office for the Western Pacific, World Health Organization, Manila, the Philippines
* The MSH Rational Pharmaceutical Management Plus Program is supported by the U.S. Agency for International Development, under the terms of cooperative agreement number HRN-A-00-00-00016-00.
© World Health Organization 2003
All rights reserved.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
The World Health Organization does not warrant that the information contained in this publication is complete and correct and shall not be liable for any damages incurred as a result of its use.
Designed by minimum graphics
Printed in France